| 摘要 |
The present invention relates to new methods for predicting the clinical outcome or determining the treatment course in a subject afflicted with colorectal cancer and for monitoring the progression of colorectal cancer in a subject. Moreover, the present invention relates to a method for stratification of therapy regimen of a subject afflicted with soild tumor entities, such as colorectal cancer, for determining its susceptibility to the treatment with an inhibitor of angiogenesis. Further, the present invention relates to kits allowing performance of the above methods. In particular, the present invention is based on the finding that determining the level or amount of angiopoietin-2 protein in a sample of a subject is useful for conducting the above referenced methods. |
